Genetically modified mesenchymal stem cells induce mechanically stable posterior spine fusion

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Traditional spine fusion relies on prosthetic devices and bone grafts, limiting biological treatment options.
• Previous research demonstrated successful spine fusion using bone morphogenetic protein-2 (BMP-2)-expressing mesenchymal stem cells (MSCs).

Purpose of the Study:

• To investigate if posterior spinal fusion using genetically modified MSCs provides mechanical stability comparable to mechanical fixation.
• To evaluate the biomechanical properties and efficacy of MSC-mediated spinal fusion.

Main Methods:

• BMP-2-expressing MSCs were injected into mouse lumbar spine paraspinal muscles, with a control group inhibiting BMP-2 expression.
• Spinal fusion was compared to a group using stainless steel pins for fixation.
• Microcomputed tomography, histological analysis, and four-point bending tests were used to assess bone formation and structural bending stiffness.

Main Results:

• Bone bridging was observed in the BMP-2-expressing MSC group, but not in control groups.
• MSC-mediated spinal fusion demonstrated effectiveness and rigidity comparable to stainless steel pin fusion.
• Stiffness distribution in the MSC group mirrored the steel pin group, with targeted fusion at L3-L5 contributing most stiffness.

Conclusions:

• MSC-induced spinal fusion provides biomechanical rigidity comparable to instrumental fixation.
• This biological approach using genetically modified MSCs is a viable alternative for achieving targeted spinal fusion.